$2.62M Accutane Verdict

The New Jersey Law Journal (via law.com) reports that a New Jersey jury awarded $2.5M in damages, and $119,000 for past medicals against Hoffman La-Roche and its Swiss parent company.  The jury found that the warning label on the acne drug Accutane failed to warn of the risk of inflammatory bowel disease.  The jury did not award any punitive damages.

– SBS